Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series—Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC
Adnan Zaidi(University of Saskatchewan), Mike Moser(Roswell Park Comprehensive Cancer Center), Shahida Ahmed(CancerCare Manitoba), Duc Le(University of Saskatchewan), Janine M. Davies(Australian Wildlife Conservancy), Bryan Brunet(University of Saskatchewan), Shahid Ahmed(Emory University), Richard M. Lee‐Ying(Alberta Health Services), Pamela Hebbard(University of Manitoba), John Paul McGhie(BC Cancer Agency), Christina Kim, Howard J. Lim(BC Cancer Agency), Jason Y. Park(Southwestern Medical Center), David Liu(Bristol-Myers Squibb (Germany)), Ralph Wong(CancerCare Manitoba), Corinne Doll(University of Calgary), Vallerie Gordon(Memorial Sloan Kettering Cancer Center), Dorie-Anna Dueck(University of Saskatchewan), Daniel J. Renouf(BC Cancer Agency), Devin Schellenberg(Surrey Place Centre), Karen Mulder
Cited by 1
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway
|Mucosal Immunology|2014|1.2k